Company / SG&A per Share
Harmony Biosciences Holdings, Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.67
FY2025
5-year range
$0.64 / $2.67
FY2021-FY2025
Trend
+37.3%
vs FY2024
Sector context
#69 of 210
Health Care
What the data says
At $2.67, Harmony Biosciences Holdings, Inc.'s sg&a per share ranks #142 of 210 in the Health Care sector. SG&A per Share has increased for 4 consecutive years, from $0.64 in FY2021 to $2.67 in FY2025.
Based on SEC 10-K filings.
2.67 in FY2025 with a 5-year CAGR of -10.6%.
Increased from $1.60 to $2.67 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +23.2%
- 5-Year CAGR
- -10.6%
- 10-Year CAGR
- -
Sector benchmark
#142 of 210 in Health CareTop 67% of 210This company $2.67 Sector average $29.50
▼
-91.0% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 37.3% year-over-year.
- Ranks #69 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.67 | +37.3% |
| FY2024 | $1.94 | +21.6% |
| FY2023 | $1.60 | +11.9% |
| FY2022 | $1.43 | +123.2% |
| FY2021 | $0.64 | -86.3% |
| FY2020 | $4.68 | -0.1% |
| FY2019 | $4.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026